Similar Papers

Paper Title
Journal
Date
Author
The effect of infliximab dose escalation in inflammatory bowel disease patients with antibodies to infliximab.
Gloria S.Z Tun ... Kerry Robinson
European journal of gastroenterology & hepatology | VOL. 34
Gloria S.Z Tun, et. al.Gloria S.Z Tun ... Kerry Robinson
06 Oct 2021
PTH-088 Prevalence of low drug levels and anti-drug antibodies in an unscreened population of patients with inflammatory bowel disease receiving infliximab
...
Gut | VOL. 66
, et. al. ...
01 Jul 2017
PTH-110 Antibodies to infliximaboccur throughout treatment but development is delayed by immunosuppression
...
Gut | VOL. 66
, et. al. ...
01 Jul 2017
Tu1315 Loss of Response in IBD Patients on Infliximab Treatment: Assay of Infliximab Trough Levels and Total Antibodies to Infliximab
Luisa Guidi ... Alessandro Armuzzi
Gastroenterology | VOL. 148
Luisa Guidi, et. al.Luisa Guidi ... Alessandro Armuzzi
01 Apr 2015
View more papers

More From: Gut

Paper Title
Journal
Date
Author
Carbon footprinting and environmental impact of gastrointestinal endoscopy procedures at a tertiary care institution: a prospective multi-dimensional assessment
Hardik Rughwani ... D Nageshwar Reddy
Gut | VOL. -
Hardik Rughwani, et. al.Hardik Rughwani ... D Nageshwar Reddy
04 Feb 2025
Dysbiotic oral microbiota-derived kynurenine, induced by chronic restraint stress, promotes head and neck squamous cell carcinoma by enhancing CD8+ T cell exhaustion
Fangzhi Lou ... Xin Jin
Gut | VOL. -
Fangzhi Lou, et. al.Fangzhi Lou ... Xin Jin
04 Feb 2025
Single-cell omics in inflammatory bowel disease: recent insights and future clinical applications
Victoria Gudiño ... Azucena Salas
Gut | VOL. -
Victoria Gudiño, et. al.Victoria Gudiño ... Azucena Salas
04 Feb 2025
Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer
Thomas L Ekstrom ... Steven A Johnsen
Gut | VOL. -
Thomas L Ekstrom, et. al.Thomas L Ekstrom ... Steven A Johnsen
30 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.